The COVID-19, the disease caused by a novel coronavirus and named severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly across the globe. It …

To address the COVID-19 pandemic, there has been an unprecedented global effort to
advance potent neutralizing mAbs against SARS-CoV-2 as therapeutics. However, historical …

Oral inhalation is the preferred route for delivery of small molecules to the lungs, because
high tissue levels can be achieved shortly after application. Biologics are mainly …

Inhalation therapy allows conveying drugs directly into the airways. The devices used to
administer inhaled drugs play a crucial role in the management of obstructive lung diseases …

Nanocarriers can deliver drugs to specific organs or cells, potentially bridging the gap
between a drug's function and its interaction with biological systems such as human …

In the 24 years since first being marketed, the mesh nebulizer has been developed by five
main manufacturers into a viable solution for the delivery of high-value nebulized drugs …

Microorganisms that make up the local microbiota (such as Lactobacillus sp. and
Bifidobacterium sp.) play a crucial role in the modulation of diseases and health states by …

Abstract Coronavirus Disease 2019 (COVID-19) pandemic has been on the agenda of
humanity for more than 2 years. In the meantime, the pandemic has caused economic …

Aerosolization of immunotherapies poses incredible potential for manipulating the local
mucosal-specific microenvironment, engaging specialized pulmonary cellular defenders …

Current guidelines recommend inhalation therapy as the preferred route of drug
administration for treating patients with chronic obstructive pulmonary disease (COPD) …